carbidopa and levodopa
Generic: carbidopa and levodopa
Labeler: alembic pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
carbidopa and levodopa
Generic Name
carbidopa and levodopa
Labeler
alembic pharmaceuticals limited
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
carbidopa 50 mg/1, levodopa 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
46708-333
Product ID
46708-333_a85a56c5-44dd-41d4-ac1c-bdc4758406a4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210341
Listing Expiration
2026-12-31
Marketing Start
2019-06-06
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
46708333
Hyphenated Format
46708-333
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbidopa and levodopa (source: ndc)
Generic Name
carbidopa and levodopa (source: ndc)
Application Number
ANDA210341 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
- 200 mg/1
Packaging
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-30)
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-31)
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-91)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a85a56c5-44dd-41d4-ac1c-bdc4758406a4", "openfda": {"nui": ["N0000193220", "M0370111", "N0000175754", "N0000175755"], "upc": ["0346708332303", "0346708333300"], "unii": ["46627O600J", "MNX7R8C5VO"], "rxcui": ["308988", "308989"], "spl_set_id": ["a85a56c5-44dd-41d4-ac1c-bdc4758406a4"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "pharm_class_epc": ["Aromatic Amino Acid [EPC]", "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-30)", "package_ndc": "46708-333-30", "marketing_start_date": "20190606"}, {"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-31)", "package_ndc": "46708-333-31", "marketing_start_date": "20190606"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-91)", "package_ndc": "46708-333-91", "marketing_start_date": "20190606"}], "brand_name": "Carbidopa and Levodopa", "product_id": "46708-333_a85a56c5-44dd-41d4-ac1c-bdc4758406a4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Amino Acids", "Aromatic [CS]", "Aromatic Amino Acid [EPC]"], "product_ndc": "46708-333", "generic_name": "Carbidopa and Levodopa", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbidopa and Levodopa", "active_ingredients": [{"name": "CARBIDOPA", "strength": "50 mg/1"}, {"name": "LEVODOPA", "strength": "200 mg/1"}], "application_number": "ANDA210341", "marketing_category": "ANDA", "marketing_start_date": "20190606", "listing_expiration_date": "20261231"}